SCHEMBL20122421

SCHEMBL20122421

Cc1oc(=O)oc1COC(=O)SC(C)(C)C(=O)N[C@@H](CS)C(=O)OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122452 0.92 FOLH1 (0.32) —
SCHEMBL20122420 0.90 FOLH1 (0.31) —
SCHEMBL20122426 0.89 — —
SCHEMBL20122415 0.89 FOLH1 (0.30) —
SCHEMBL20122412 0.89 KDM4E (0.33) —
SCHEMBL20122453 0.88 — —
SCHEMBL20122370 0.85 — —
SCHEMBL20122390 0.84 — —
SCHEMBL20122566 0.84 CHRM1 (0.34) —
SCHEMBL20122529 0.84 TACR1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback